Sanofi ADR
NASDAQ: SNY
$50.11
+$1.14 (+2.3%)
Closing Price on June 25, 2024
SNY Articles
Source: ThinkstockRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab)...
Published:
Last Updated:
When the American Society of Clinical Oncology (ASCO) decided to create a rating scale for cancer drugs, it certainly must have expected to get some pushback.
Published:
Last Updated:
This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more than just one drug candidate.
Published:
After looking at the recent recovery, and after looking over the more recent news that has come out after earnings, 24/7 Wall St. wants to see if MannKind shares have finally reached their bottom.
Published:
Biotech company MannKind reported its first-quarter financial results after the markets closed Thursday.
Published:
Thursday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Coach, Garmin, Intelsat, Potbelly, SolarCity and Valero Energy.
Published:
Source: courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has made its quarterly filing with the Securities & Exchange Commission for its holdings as of December 31, 2014. For all...
Published:
At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks.
Published:
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
Published:
Last Updated:
Source: courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some...
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, October 29, 2014.
Published:
Source: courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) released its public equity holdings as of June 30, 2014. Warren Buffett’s different portfolio holdings have not been changing...
Published:
Last Updated:
Source: Jon OggMannKind Corp. (NASDAQ: MNKD) was supposed to be a huge winner on this week’s news that Sanofi (NYSE: SNY) will become its global partner for its inhalable insulin Afrezza....
Published:
Source: ThinkstockMannKind Corp. (NASDAQ: MNKD) was supposed to be in the news for its earnings report. Instead, we got news of its strategy on how to get its Afrezza inhalable insulin to the market....
Published:
The Department of Defense awarded $409 million in defense contracts Friday. Hewlett Packard won the day's largest award. The company will continue to providing information technology services at...
Published: